Cargando…

Re-irradiation for recurrent or second primary head and neck cancer

PURPOSE: To investigate the efficacy and safety of intensity-modulated radiotherapy (IMRT)-based re-irradiation (reRT) for recurrent or second primary head and neck cancer (HNC). MATERIALS AND METHODS: Patients who underwent IMRT-based reRT for recurrent or second primary HNC between 2007 and 2019 a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hye In, Kim, Jin Ho, Ahn, Soon-Hyun, Chung, Eun-Jae, Keam, Bhumsuk, Eom, Keun-Yong, Jeong, Woo-Jin, Kim, Ji-Won, Wee, Chan Woo, Wu, Hong-Gyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Radiation Oncology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743457/ https://www.ncbi.nlm.nih.gov/pubmed/34986549 http://dx.doi.org/10.3857/roj.2021.00640

Ejemplares similares

A Phase II Study of Genexol‐PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Keam, Bhumsuk, et al.
Publicado: (2019)

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
por: Rühle, Alexander, et al.
Publicado: (2020)

Proton re-irradiation of unresectable recurrent head and neck cancers
por: Gordon, Konstantin, et al.
Publicado: (2021)

TRIUMPH Trial: One Small Step Could Become One Giant Leap for Precision Oncology in Head and Neck Cancer
por: Keam, Bhumsuk, et al.
Publicado: (2019)

Feasibility and safety of neck level IB-sparing radiotherapy in nasopharyngeal cancer: a long-term single institution analysis
por: Kim, Dowook, et al.
Publicado: (2022)

A retrospective study of head and neck re-irradiation for patients with recurrent or second primary head and neck cancer: the McGill University experience
por: Al-Wassia, Rolina, et al.
Publicado: (2015)

Re-Irradiation for Recurrent Head and Neck Cancer: Freedom from Cancer Recurrence Rate
por: Mohamad, Issa, et al.
Publicado: (2023)

Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy
por: Jeong, Songmi, et al.
Publicado: (2013)

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2017)

Efficacy of Prophylactic Cranial Irradiation According to the Risk of Extracranial Recurrence in Limited-Stage Small Cell Lung Cancer
por: Lee, Tae Hoon, et al.
Publicado: (2023)

Re-irradiation of a second localization of idiopathic midline destructive disease in the head and neck area
por: Poorter, Robert L., et al.
Publicado: (2007)

Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)
por: Kang, Eun Joo, et al.
Publicado: (2022)

Prognostic value of the association between MHC class I downregulation and PD-L1 upregulation in head and neck squamous cell carcinoma patients
por: Yoo, Shin Hye, et al.
Publicado: (2019)

Treatment strategy and outcomes in locally advanced head and neck squamous cell carcinoma: a nationwide retrospective cohort study (KCSG HN13–01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2020)

Comparison of Treatment Patterns and Clinical Outcomes by Gender in Locally Advanced Head and Neck Squamous Cell Carcinoma (KCSG HN13-01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2023)

Results of Free Flap Reconstruction After Ablative Surgery in the Head and Neck
por: Kim, Heejin, et al.
Publicado: (2015)

Squamous cell carcinoma of head and neck: what internists should know
por: Jung, Kyungsuk, et al.
Publicado: (2020)

Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
por: Amdal, Cecilie Delphin, et al.
Publicado: (2023)

Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
por: Yoo, Shin Hye, et al.
Publicado: (2019)

Induction Chemotherapy as a Prognostication Index and Guidance for Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: The Concept of Chemo-Selection (KCSG HN13-01)
por: Lee, Yun-Gyoo, et al.
Publicado: (2022)

Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
por: Lim, Sun Min, et al.
Publicado: (2019)

PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2016)

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
por: Lee, Yun-Gyoo, et al.
Publicado: (2021)

Effect of National Oral Health Screening Program on the Risk of Head and Neck Cancer: A Korean National Population-Based Study
por: Wee, Chan Woo, et al.
Publicado: (2022)

Predictive and prognostic value of PET/CT imaging post-chemoradiotherapy and clinical decision-making consequences in locally advanced head & neck squamous cell carcinoma: a retrospective study
por: Kim, Ryul, et al.
Publicado: (2016)

Re-irradiation for oligoprogression under Nivolumab in recurrent head and neck squamous cell carcinoma: A case report
por: Bonomo, Pierluigi, et al.
Publicado: (2020)

Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy
por: Wee, Chan Woo, et al.
Publicado: (2015)

Carotid dosimetry after re-irradiation with (131)Cs permanent implant brachytherapy in recurrent, resected head and neck cancer
por: Walsh, Amanda, et al.
Publicado: (2019)

The antitumor activity of a novel GCN2 inhibitor in head and neck squamous cell carcinoma cell lines
por: Lee, Jeongjae, et al.
Publicado: (2022)

Atypical Fibroxanthoma in Head and Neck
por: Kim, Jin Pyeong, et al.
Publicado: (2014)

Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions
por: Held, Thomas, et al.
Publicado: (2019)

Re-surgery and chest wall re-irradiation for recurrent breast cancer - a second curative approach
por: Müller, Arndt-Christian, et al.
Publicado: (2011)

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
por: Ha, Hyerim, et al.
Publicado: (2021)

Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
por: Jang, Na Young, et al.
Publicado: (2012)

Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapy
por: Stuschke, Martin, et al.
Publicado: (2013)

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer
por: Koukourakis, Ioannis M., et al.
Publicado: (2023)

Radiotherapy versus Surgery in Early-Stage HPV-Positive Oropharyngeal Cancer
por: Kim, Dong-Yun, et al.
Publicado: (2022)

Overlapping volumes in re-irradiation for head and neck cancer – an important factor for patient selection
por: Embring, Anna, et al.
Publicado: (2020)

The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis
por: Kim, Ryul, et al.
Publicado: (2016)

RARE-02.RE-IRRADIATION FOR RECURRENT CRANIOPHARYNGIOMA
por: Foran, Sarah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7dc4498s39pvovcic797c4cp0g